MX350475B - Uso de granos de café verdes para regular trastornos de pigmentación de la piel. - Google Patents

Uso de granos de café verdes para regular trastornos de pigmentación de la piel.

Info

Publication number
MX350475B
MX350475B MX2013001078A MX2013001078A MX350475B MX 350475 B MX350475 B MX 350475B MX 2013001078 A MX2013001078 A MX 2013001078A MX 2013001078 A MX2013001078 A MX 2013001078A MX 350475 B MX350475 B MX 350475B
Authority
MX
Mexico
Prior art keywords
skin
coffee beans
green coffee
present
skin pigmentation
Prior art date
Application number
MX2013001078A
Other languages
English (en)
Spanish (es)
Other versions
MX2013001078A (es
Inventor
Kraehenbuehl Karin
Dionisi * Fabiola
Guitard Marjorie
Moodycliffe Angus
Mauroux Olivier
Original Assignee
Loreal *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loreal * filed Critical Loreal *
Publication of MX2013001078A publication Critical patent/MX2013001078A/es
Publication of MX350475B publication Critical patent/MX350475B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2013001078A 2010-07-30 2011-07-29 Uso de granos de café verdes para regular trastornos de pigmentación de la piel. MX350475B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10171376 2010-07-30
PCT/EP2011/063088 WO2012013776A2 (en) 2010-07-30 2011-07-29 Use of green coffee beans for regulating skin pigmentation disorders

Publications (2)

Publication Number Publication Date
MX2013001078A MX2013001078A (es) 2013-03-12
MX350475B true MX350475B (es) 2017-09-07

Family

ID=43416787

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013001078A MX350475B (es) 2010-07-30 2011-07-29 Uso de granos de café verdes para regular trastornos de pigmentación de la piel.

Country Status (7)

Country Link
EP (1) EP2598102A2 (zh)
JP (1) JP2013533282A (zh)
CN (1) CN103079525B (zh)
BR (1) BR112013002215B1 (zh)
MX (1) MX350475B (zh)
RU (1) RU2013108968A (zh)
WO (1) WO2012013776A2 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014044591A1 (en) * 2012-09-21 2014-03-27 Nestec S.A. Composition comprising plant phenols for preventing or reducing tewl and associated disorders and diseases
US20150209399A1 (en) * 2013-12-05 2015-07-30 Applied Food Sciences, Inc. Methods For Enhacement Of Dehydroepiandrosterone Using Green Coffee Bean Extract
WO2017173240A1 (en) 2016-03-31 2017-10-05 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017240069B2 (en) 2016-03-31 2024-03-07 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
BR102016019123A2 (pt) * 2016-08-17 2018-03-06 Natura Cosméticos S.A. Composição cosmética antissinais, uso da composição, método de tratamento antissinais e método para clareamento de olheiras e/ou tratamento de bolsas nos olhos
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
US20200222358A1 (en) 2019-01-15 2020-07-16 Derma Research Group Inc. Topical dermatologic acne treatment cream composition and method of manufacture
CN113729034A (zh) * 2021-07-30 2021-12-03 阿特美生物科技(海南)有限公司 一种二元喷雾植物萃取物的空气消毒剂及其制备方法
FR3135992A1 (fr) * 2022-05-25 2023-12-01 L'oreal Signature moléculaire du lentigo actinique associée à la gestion des vésicules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0826967A (ja) * 1994-07-13 1996-01-30 Ichimaru Pharcos Co Ltd クロロゲン酸又はその誘導体含有化粧料
JPH0892057A (ja) * 1994-09-16 1996-04-09 Ichimaru Pharcos Co Ltd コーヒーノキ種子抽出物配合化粧料
JPH09151130A (ja) * 1995-12-01 1997-06-10 Yakurigaku Chuo Kenkyusho:Kk 白毛症および白斑症治療薬
ES2535778T3 (es) * 2002-09-09 2015-05-14 Nestec S.A. Composición de administración oral para mejorar la calidad de la piel
AU2003290130B2 (en) * 2002-12-13 2008-06-05 L'oreal Use of an extract of decaffeinated coffee beans in the preparation of a composition intended to stimulate the sebaceous function of the skin by oral administration
FR2848448B1 (fr) * 2002-12-13 2007-04-06 Oreal Utilisation d'un extrait de grains de cafe decafeine dans la preparation d'une composition destinee a stimuler la fonction sebacee de la peau par administration orale
WO2005032570A1 (ja) * 2003-10-06 2005-04-14 Oryza Oil & Fat Chemical Co., Ltd. ダイエット用組成物
JP2006335758A (ja) * 2003-10-06 2006-12-14 Oriza Yuka Kk ダイエット用組成物
KR101196043B1 (ko) * 2004-04-08 2012-10-31 브이디에프 퓨쳐슈티컬스, 인코포레이티드 커피 체리 화장품 조성물 및 방법
ATE433675T1 (de) * 2006-10-13 2009-07-15 Gervais Danone Sa Neue zusammensetzung zur verbesserung des hautzustandes und verfahren zu ihrer herstellung
US20090169651A1 (en) * 2007-06-28 2009-07-02 Muhammed Majeed Anti-skin damage compositions with complimentary dual mode of action

Also Published As

Publication number Publication date
CN103079525A (zh) 2013-05-01
EP2598102A2 (en) 2013-06-05
WO2012013776A2 (en) 2012-02-02
BR112013002215A2 (pt) 2016-05-24
CN103079525B (zh) 2018-03-09
RU2013108968A (ru) 2014-09-10
BR112013002215B1 (pt) 2017-12-19
JP2013533282A (ja) 2013-08-22
WO2012013776A3 (en) 2012-03-22
MX2013001078A (es) 2013-03-12

Similar Documents

Publication Publication Date Title
MX349209B (es) Uso de granos de cafe tostados para regular pigmentación de la piel.
MX350475B (es) Uso de granos de café verdes para regular trastornos de pigmentación de la piel.
MX350476B (es) Uso de una mezcla de granos de cafe tostados y verdes para regular pigmentacion de la piel.
MX355430B (es) Compuestos de resorcinol para uso dermatologico.
WO2013062266A3 (ko) 약용 꽃을 활용한 쌈 발효법 및 이를 활용한 피부 외용제 조성물
MX2011012547A (es) Extractos de te verde con una mejor biodisponibilidad.
WO2011126295A3 (ko) 약용 잎을 활용한 쌈 발효법 및 이를 활용한 피부 외용제 조성물
WO2011122869A3 (ko) 쿠메스트롤 또는 쿠메스트롤을 포함하는 콩 추출물을 포함하는 피부 미용용 조성물
MX2017011830A (es) Fitocomplejos que exhiben actividades antioxidantes sinergicas, multiples, utiles en alimentos, suplementos alimenticios, cosmeticos y preparaciones farmaceuticas.
BR112012032877A2 (pt) uso de ácido chicórico e derivados para regulagem de pigmentação da pele
MX338286B (es) El uso de ácido cicórico y bacteria láctica en complemento alimenticio para regular la pigmentación de la piel.
MX357554B (es) Concentrado o extracto de brote de aloe vera que tiene efectos superiores de promoción de célula de la piel, antioxidantes y anti-alergia.
WO2013055127A3 (ko) 어성초 추출물을 유효성분으로 함유하는 치매, 파킨슨병 또는 간질 예방 및 치료용 약학적 조성물
MX349208B (es) El uso de ácido caftárico y derivados en complemento alimenticio para regular la pigmentación de la piel.
WO2012070835A3 (ko) 모자반 추출물, 청각 추출물 및 참미역 추출물을 함유하는 화장료 조성물
WO2011126322A3 (ko) 검정콩 추출물을 포함하는 퇴행성 뇌신경 질환 치료 또는 예방용 조성물
TW201129394A (en) Composition for inhibiting melanogenesis and use thereof
MX347326B (es) El uso de ácido caftárico y bateria láctica en complemento alimenticio para regular la pigmentación de la piel.
MX358237B (es) Uso de café verde y probiótico para regular pigmentación de la piel.
MX2019001852A (es) Metodos y composiciones para reducir el encanecimiento.
WO2014096083A3 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
TW201613555A (en) Preparation method of herbal composition with multi-functional skin protection and application thereof
WO2012091730A3 (en) Indole alkaloid compounds as melanogenesis promoters and uses thereof
WO2014005815A3 (de) Wirkstoffkombinationen aus magnolienrindenextrakt und anisfruchtextrakt und ihre kosmetische und/oder dermatologische verwendung
WO2012013417A3 (en) Skin care compositions comprising substituted diamines

Legal Events

Date Code Title Description
FG Grant or registration